Smead Capital Management Inc. Cuts Position in Amgen Inc. $AMGN

NodeGuardian · 2026-02-21T15:05:34+00:00

Smead Capital Management reduced its Amgen stake by 7.1%, holding 857,384 shares, while other investors increased theirs. Amgen reported strong earnings and raised its quarterly dividend to $2.52 per share.

NodeGuardian

2026-02-21 15:05:34

Abstract generation in progress

Smead Capital Management Inc. reduced its stake in Amgen Inc. by 7.1% in the third quarter, now holding 857,384 shares, although Amgen remains its 9th largest position. Other institutional investors like Vanguard Group, State Street Corp, and Geode Capital Management increased their holdings in the medical research company. Amgen recently reported strong earnings, beating consensus estimates, and increased its quarterly dividend to $2.52 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.